Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now has funded $30,229,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 199 grants at over 100 hospitals in 29 countries.


Sydney Children's Hospital - $100,000 USD / $105,370 AUD (Approx)

Amount
$100,000.00 USD
Date
January 2013

Research of treatments for Diffuse Intrinsic Pontine Glioma (DIPG)

Grant Information

Sydney Children's Hospital - $100,000 USD / $100,420 AUD (Approx)

Amount
$100,000.00 USD
Date
August 2011

Robotic screening for novel therapies for diffuse pontine gliomas

Grant Information

Children's National Medical Center – $1,000,000 (Installment 1 of 4)

Amount
$250,000.00 USD
Date
October 2026

SPARC‑T: Spatially Programmed and Remotely Controlled CAR T-Cell Immunotherapy for Pediatric Brain Tumors

Grant Information

Seattle Children's Hospital - $1,000,000 (Installment 2 of 4)

Amount
$250,000.00 USD
Date
October 2026

Augmentation of the tumor immune microenvironment to enhance B7-H3 CAR T cell efficacy against diffuse midline glioma

Grant Information

Columbia University Irving Medical Center – $100,000

Amount
$100,000.00 USD
Date
December 2025

Targeting DIPG Through Therapeutic Dietary Intervention

Grant Information

Johns Hopkins University School of Medicine – $50,000

Amount
$50,000.00 USD
Date
December 2025

Identifying Novel Treatment Combinations Targeting ERK Signaling Dependence in Pediatric Glioma

Grant Information

University of Virginia Medical Center – $100,000

Amount
$100,000.00 USD
Date
December 2025

Targeting Alternatively Activated Macrophages in Diffuse Midline Glioma

Grant Information

Kiragen Bio – $50,000

Amount
$50,000.00 USD
Date
December 2025

Engineering Suppression-Resistant CAR-T Cells for the Treatment of Pediatric DIPG by Overcoming the Tumor Microenvironment

Grant Information

Seattle Children’s Hospital – $50,000

Amount
$50,000.00 USD
Date
December 2025

Thyroid Hormone Therapy in Combination with Chemotherapy for Pediatric Medulloblastoma

Grant Information

University of Rome Tor Vergata – $100,000 USD / €85,232 EUR

Amount
$100,000.00 USD
Date
December 2025

Reprogramming the tumor immune landscape: combined use of NK cells and radiotherapy in high-risk medulloblastoma

Grant Information

Weill Cornell Medicine – $50,000

Amount
$50,000.00 USD
Date
December 2025

A Phase 1a Open-label Study Evaluating the Safety of 177Lu-DTPA-omburtamab delivered by CED in non-progressive DMG patients previously treated with external beam radiation therapy

Grant Information

The Hebrew University of Jerusalem – $50,000 USD / 159,344.25 New Israeli Shekels

Amount
$50,000.00 USD
Date
December 2025

Uncovering and Exploiting Tumor Vulnerabilities in Medulloblastoma via Integrated Genomic and Preclinical Platforms.

Grant Information

Cincinnati Children’s Hospital Medical Center – $75,000

Amount
$75,000.00 USD
Date
December 2025

Multiomic Characterization of Central Nervous System Tumors Using Whole Methylome and Comprehensive High-Depth DNAseq and RNAseq to Assess Impact on Historical Patient Diagnoses and Outcomes

Grant Information

University of Alabama at Birmingham Hospital - $200,000

Amount
$200,000.00 USD
Date
December 2025

Precision Immunotherapy for Diffuse Midline Glioma Targeting

Grant Information

Icahn School of Medicine at Mount Sinai – $100,000

Amount
$100,000.00 USD
Date
December 2025

Targeting DMG Microenvironment with LSD1 Inhibitors

Grant Information